The goal is to recruit up to 30,000 physical care staff worldwide, adding 500 to 1,000 in the St. Louis area.
The University of Washington is an essay with University College London and the University of Witwatersrand in Johannesburg.
The MMR vaccine was approved about 50 years ago and has since been safely given to millions of people, in particular by reducing the onset of the disease. The vaccine is given in two doses to a child before age 6.
Although the vaccine provides lifetime coverage against all 3 diseases, there is on-the-record evidence that an adult booster would possibly cause a broad immune reaction to the formula that can also save you coronavirus infection for several months.
This is because the MMR vaccine contains small amounts of weakened live viruses; and there are similarities between these viruses and the new coronavirus. They have similar proteins on their surfaces that are related to infection of the body’s cells.
Researchers that young antibodies produced in reaction to the MMR vaccine can recognize and fight the coronavirus.
“This type of vaccine appears to be the body’s immune reaction to infections in general, not just the viruses in this specific vaccine,” said one of the lead researchers on the collaboration, Dr. Michael Avidan, director of the Department of Anesthesiology at the University of Washington.
The MMR vaccine would not be used to treat the disease, but researchers should know whether a booster injection can delay the spread of coronavirus and physical care staff working in high-risk environments for COVID-19 progression. get tested to see if it reduces the severity of the disease for infected people.
Dr Laurence Lovat, who led the study in the UK, said that if the MMR vaccine can simply bring the body’s overall immune response to life, it could contribute to the effectiveness of the first COVID-19 vaccines, which could be approved. until the end of the year or earlier.
“If we notice that the MMR vaccine can exercise the body’s immune reaction to SARS-CoV-2 infection (the new coronavirus), then we will have anything to administer very quickly, until more rapid vaccines and preventive treatments develop,” Lovat said in a statement.
The countries involved in the review are Canada, Ghana, Ireland, South Africa, Uganda, the United Kingdom, the United States, Zambia and Zimbabwe. In many of these countries, there are few fitness personnel consistent with capital. Some will get the MMR Vaccine for the first time.
Protecting staff from a severe COVID-19 infection can ensure that the public is cared for and reduce the spread of the virus in the community.
“We designed the exam to focus on fitness care staff based on the availability of this important workforce around the world,” said Mary Politi, a fitness psychology researcher and professor of surgery at the University of Washington. “There are many other vulnerable teams in settings such as networked life centers or schools, and we hope to find quick hits so we can share this wisdom with other high-risk teams. “
It uses the global network of COVID-19 (CROWN) research results to carry out the matrix. The network introduced at the beginning of the global pandemic reaches the study establishments of African, European and North American countries.
The network has been designed to be able to adapt temporarily to the examination of other interventions. CROWN participated in a plan to examine the antimalarial drug chloroquine to treat COVID19 before knowledge showed that the drug is not as promising as originally thought.
“The CROWN collaborative study platform designed to temporarily compare preventive and curative interventions to locate which ones they paint and which don’t,” Avidan said. “Our purpose from the beginning has been to identify the interventions they paint and make them have other people around the world who will get more advantages. “